Health Care [ 2/12 ] | Biotechnology [ 19/74 ]
NASDAQ | Common Stock
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.
Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.
The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer.
The company is headquartered in Jerusalem, Israel.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 19, 26 | -0.26 Decreased by -136.36% | -0.12 Decreased by -110.36% |
| Mar 5, 26 | -0.14 Decreased by -7.69% | -0.12 Decreased by -13.54% |
| Nov 20, 25 | -0.39 Decreased by -290.00% | -0.12 Decreased by -225.00% |
| Aug 11, 25 | -0.13 Decreased by -18.18% | -0.11 Decreased by -18.18% |
| May 19, 25 | -0.11 Increased by 0.00% | -0.13 Increased by +15.38% |
| Mar 12, 25 | -0.13 Decreased by -18.18% | -0.13 |
| Nov 19, 24 | -0.10 Decreased by -42.86% | -0.12 Increased by +16.87% |
| Aug 14, 24 | -0.11 Increased by +8.33% | -0.11 |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 0.00 Decreased by N/A% | -22.94 M Decreased by -163.94% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 25 | 0.00 Decreased by N/A% | -12.14 M Decreased by -28.07% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -11.69 M Decreased by -68.78% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -10.11 M Decreased by -37.25% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -8.69 M Decreased by -8.90% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -9.48 M Decreased by -28.66% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -6.92 M Decreased by -40.96% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -7.37 M Increased by +15.23% | Decreased by N/A% Decreased by N/A% |